![](/img/cover-not-exists.png)
An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin
H. Hirte, D. Stewart, R. Goel, E. Chouinard, S. Huan, S. Stafford, B. Waterfield, S. Matthews, C. Lathia, B. Schwartz, V. Agarwal, R. Humphrey, and L. SeymourVolume:
23
Language:
english
Pages:
7
DOI:
10.1007/s10637-005-2903-3
Date:
October, 2005
File:
PDF, 69 KB
english, 2005